Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
While no oncologist can be an expert in every type of cancer, GRACE does not aim to replace your doctors. Our faculty are specialists in their fields, focusing on specific types of cancer. GRACE connects experts with patients and families, fostering a community where information is shared, and everyone can learn from one another. We provide balanced, evidence-based cancer information from a core group of experts, accessible in various formats to cater to different needs.
In the GRACE forums, you can ask questions or share comments, which will be addressed by our skilled moderators and experts. This opens up opportunities for informative discussions with others who may have similar concerns or insights. Through communication and collaboration, we believe some of the most valuable information emerges. All content on cancerGRACE.org is free, accessible, and searchable, so you can find the information you need at any time. GRACE offers a supportive community for heartfelt discussions, virtual hugs, and connections whenever you need them.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended. ¡Los vídeos están disponibles BAJO DEMANDA! Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas. Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y...
GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26 Program Year! Applications for this program are open in March every year. To be notified when applications for this program open, please email Amy Bickleman, Executive Director, at abickleman@cancergrace.org to be added to the notification list. All four candidates have shown a genuine passion for patient education and innovation in connecting with...
Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias dirigidas de cáncer pulmón de GRACE en ESPAÑOL. Es un evento educativo para pacientes en vivo, virtual e interactivo, que incluye presentaciones y mesas redondas que cubren una diversa gama de cánceres de pulmón y opciones de tratamiento. Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y mesas redondas que...
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program We are thrilled to introduce this year’s participants in the Clinical Trials Storytelling Program! Representing diverse cancer types and a range of clinical trial experiences, these incredible individuals will collaborate with GRACE to create meaningful content across multiple platforms. Through their stories, they will become established contributors...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: